Definition
A summary of the key literature on the virological, immunological, and clinical progression of HIV-2-infected individuals, with emphasis on the contrast between HIV-2 and HIV-1.
Natural History and Viral Load
The single most distinguishing feature of HIV-2 compared to HIV-1 is its much lower viral load set point. There are no data on the viral loads achieved during the acute phase of HIV-2 infection and less data than for HIV-1 on the viral loads maintained during chronic infection, limiting the precision of viral load estimates at a population level. The viral loads of individuals with untreated chronic HIV-2 infection show considerable variability. While a minority of those infected with HIV-2 have viral burdens typical of progressive HIV-1 infections, in approximately 80% of HIV-2-infected individuals, viral loads remain very low or, in up to perhaps a third of cases, undetectable (Grant et al. 1997; van der Loeff et al. 2010). This is in contrast to HIV-1, where only 1%...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ariyoshi K, Schim van der Loeff M, et al. Kaposi’s sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol. 1998;1(3):193–9.
Ariyoshi K, Jaffar S, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS. 2000;14(4):339–44.
Camacho RJ. Special aspects of the treatment of HIV-2-infected patients. Intervirology. 2012;55(2):179–83.
de Silva TI, Cotten M, et al. HIV-2: the forgotten AIDS virus. Trends Microbiol. 2008;16(12):588–95.
de Silva T, Leligdowicz A, et al. Effect of HIV-2 infection on HIV-1 disease progression. N Engl J Med. 2012;367(20):1961–2. author reply 1962–1963.
de Silva TI, van Tienen C, et al. Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic. AIDS. 2013;27(1):125–34.
Drylewicz J, Eholie S, et al. First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration. AIDS. 2010;24(7):1043–50.
Esbjornsson J, Mansson F, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med. 2012;367(3):224–32.
Gottlieb GS, Sow PS, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis. 2002;185(7):905–14.
Gottlieb GS, Hawes SE, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS. 2006;20(6):895–900.
Grant AD, Djomand G, et al. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS. 1997;11(Suppl B):S43–54.
Hawes SE, Critchlow CW, et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst. 2006;98(2):100–9.
Jaffar S, Grant AD, et al. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ. 2004;82(6):462–9.
Leligdowicz A, Rowland-Jones S. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection. Expert Rev Vaccines. 2008;7(3):319–31.
Lucas SB, Hounnou A, et al. The mortality and pathology of HIV infection in a west African city. AIDS. 1993;7(12):1569–79.
MacNeil A, Sarr AD, et al. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007;81(10):5325–30.
Martinez-Steele E, Awasana AA, et al. Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS. 2007;21(3):317–24.
Ndour M, Sow PS, et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986–97 at Fann Hospital in Dakar, Senegal. Tropical Med Int Health. 2000;5(10):687–91.
Peterson I, Togun O, et al. Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia. AIDS. 2011a;25(17):2167–75.
Peterson K, Jallow S, et al. Antiretroviral therapy for HIV-2 infection: recommendations for management in low-resource settings. AIDS Res Treat. 2011b;2011:463704.
Saksena NK, Rodes B, et al. Elite HIV controllers: myth or reality? AIDS Rev. 2007;9(4):195–207.
van der Loeff MF, Larke N, et al. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology. 2010;7:46.
Weiss R, Boshoff C. Addressing controversies over Kaposi’s sarcoma. J Natl Cancer Inst. 2000;92(9):677–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this entry
Cite this entry
Peterson, K. (2018). Natural History and Clinical Features of HIV-2 Infection. In: Hope, T.J., Richman, D.D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7101-5_39
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7101-5_39
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7100-8
Online ISBN: 978-1-4939-7101-5
eBook Packages: MedicineReference Module Medicine